What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 00173/0047.

Dioderm 0.1% w/w Cream

PACKAGE LEAFLET Information for the user

Dioderm 0.1% w/w Cream


Please read all of this leaflet carefully before you start using this product.

Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

In this leaflet:

1. What Dioderm is and what it is used for
2. Before you use Dioderm
3. How to use Dioderm
4. Possible side effects
5. How to store Dioderm
6. Further information


  • Dioderm is a medicine for application to the skin to treat eczema and dermatitis (areas of dry, red, inflamed, itchy skin).
  • Dioderm is suitable for use by adults, the elderly, children and infants.
  • The active ingredient in this product is hydrocortisone. This is one of a group of medicines called corticosteroids (which should not be confused with ‘anabolic steroid’ tablets or injections misused by some athletes).
  • The product works by reducing the redness, inflammation and itching associated with these skin problems.


Do not use Dioderm:

  • if you are allergic (hypersensitive) to hydrocortisone or any of the other ingredients of Dioderm listed in Section 6;
  • to treat any other skin problems, especially skin infections, as it may make them worse;
  • on open wounds, ulcers or broken skin.

Take special care when using this product:

  • Tell your doctor if at any stage you think any of the skin area being treated has become infected. Your doctor may advise you to stop using Dioderm for a while and start using an alternative anti-microbial treatment instead.
  • Keep the product away from the eyes.
  • Although hydrocortisone is generally regarded as safe, even for long term use, do not use this product excessively:
    • avoid using this product continuously or frequently for long periods (weeks or months on end);
    • this is especially important if you are using it over large areas, on the face or under airtight bandages or dressings;
    • for infants and babies it is very important not to over-use this product, so treatment should normally be limited to no longer than 7 days.

Using other medicines

Dioderm is not known to affect, or to be affected by, any other medicines.

Pregnancy and breast-feeding

It is unclear whether this product is safe for use during pregnancy and breast-feeding. Animal birth defects have occurred with similar medicines containing corticosteroids, so there may be a very small risk of these problems in humans.

You should therefore not normally use this product if you are pregnant or breast-feeding, unless your doctor has recommended you to do so.

Driving and using machinery

Using this product is not known to affect your ability to drive or use machinery.

Important information about one of the ingredients of Dioderm

The product contains a small amount of propylene glycol. This ingredient may cause skin irritation in a small number of people who are sensitive to it. If you have been told by your doctor that you are sensitive to propylene glycol, please talk to your doctor before using this product.


Use Dioderm only on eczema and dermatitis.

Before you use this tube of cream for the first time, unscrew the cap, turn it upside down and use the sharp point in the top of the cap to pierce the tube membrane.

For adults, the elderly and children:

  • Apply Dioderm to the affected areas of skin twice a day.
  • Gently massage the cream into the skin until it is absorbed.
  • Always wash your hands after use.

When you can see that the skin condition is getting better, you can start to apply Dioderm less often, only once a day or even less. The frequency of application should be reduced to the minimum necessary to keep the skin condition under control.

For infants and babies (including in the treatment of nappy rash):

  • Follow the above instructions for adults, but do not use continuously for longer than 7 days unless advised by a doctor.

If the cream accidentally gets into the eyes it may cause irritation. If it gets into the eyes, rinse immediately with plenty of water. If rinsing one eye, take care to avoid washing product into the other eye. If irritation persists, tell your doctor or pharmacist.

If you accidentally swallow some of the cream, it is unlikely to harm you but you should tell your doctor or pharmacist.

If you occasionally forget to use Dioderm, do not worry, just carry on using it when you remember.

If you have any further questions on the use of this product, ask your doctor or pharmacist.


Like all medicines, Dioderm can cause side effects, although not everybody gets them:

  • In rare cases skin irritation (such as redness or itching) may occur. If this happens stop using the product.
  • If your eczema or dermatitis seems to get worse during treatment, you may be allergic to one of the ingredients in the cream.
  • Topical corticosteroids are usually well tolerated when used in the right amount and for the correct length of time. However, prolonged, excessive use, particularly in children or on skin that is bandaged or wrapped up, can cause local skin thinning (making the skin damage easily), striae (stretch marks) and adrenal suppression (a type of hormone imbalance that causes generalised effects on the body). Stopping treatment normally corrects these side effects.

If you experience any of the above, or if you experience any other side effect not mentioned in this leaflet, stop using this product and tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom

Yellow Card Scheme at: www.mhra.gov.uk/yellowcard


HPRA Pharmacovigilance
Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971
Fax: +353 1 6762517
Website: www.hpra.ie


  • Keep out of the reach and sight of children.
  • Do not use Dioderm after the expiry date shown on the fold of the tube and carton. The expiry date refers to the last day of that month.
  • Do not store above 25°C.
  • Always replace the cap tightly after use.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.


What Dioderm contains:

The active ingredient is hydrocortisone (0.1% w/w).

The other ingredients are citric acid, emulsifying wax, white soft paraffin, liquid paraffin, propylene glycol and purified water.

What Dioderm looks like and contents of the pack

  • The product is a smooth, white cream.
  • The product is available in tubes containing 30g, fitted with screw caps.

The Marketing Authorisation holder is:

Dermal Laboratories
Tatmore Place

The Manufacturer is:

Fleet Laboratories Ltd
94 Rickmansworth Rd
WD18 7JJ

This Patient Information Leaflet was last revised in January 2015.

To listen to or request a copy of this leaflet in Braille, large print or audio, please call free of charge: 0800 198 5000 (UK only).

Please be ready to give the following information:

Dioderm, 00173/0047.

This is a service provided by the Royal National Institute of Blind People (RNIB).

CP3/15/1 201317